Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPHASIS-2
NCT07526987Phase 3Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Jun 2026; status: recruiting.
02
Drugs
minocycline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07526987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07526987.